Glycotest gets $1 million boost from Fosun for liver cancer tests
LONDON: Glycotest, a company developing blood tests for liver cancer, has received a $1 million follow-on investment from Fosun Industrial Co., Limited, a Chinese conglomerate....
Glycotest receives $3mn second tranche of $10mn Series A financing
NEW YORK: Glycotest, Inc., a diagnostics company commercializing new and unique blood tests for life threatening liver cancers and fibrosis-cirrhosis, has received the second $3...